MT2A and esophageal cancer: The effects of MT2A are mediated through the expression and secretion of insulin-like growth factor binding protein (IGFBP)2 via NFκB, AKT, and ERK signaling, and high MT2A expression correlates with poor prognosis in esophageal cancer patients [475].